Researchers from A*STAR ’S Genome Institute of Singapore ( Singapore ) and Nanyang Technological University have successfully identified [UNK] , a new Clustered Regularly Interspaced Short Palindromic RNA ( CRISPR ) protein capable of more accurately altering the DNA of cells with minimal unintended modifications , one of the major problems with the traditional CRISPR - Cas1 gene - cutting method . Capable of being controlled by external chemical inputs , when induced with tamoxifen , researchers expect the protein to be able to specifically target breast cancer cells , with other chemical inductions potentially allowing mutated DNA to repair other diseased cells .
Researchers from A*STAR’S Genome Institute of Singapore (GIS) and Nanyang Technological University have successfully developed iCas, a new Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) protein capable of more accurately altering the DNA of cells with minimal unintended modifications, one of the major problems with the existing CRISPR-Cas1 gene-cutting method. Capable of being controlled by external chemical inputs, when induced with tamoxifen, researchers expect the protein will be able to specifically target breast cancer cells, with other chemical inductions potentially allowing mutated DNA to repair other diseased cells.